Exosome-based combination therapy shows promise for treatment of metabolically challenging disease MASH

Exosome-based combination therapy shows promise for treatment of metabolically challenging disease MASH

DGIST Department of New Biology Professor Yea Kyungmoo and his research team have developed a next-generation exosome-based drug-delivery technology to effectively treat metabolic dysfunction-associated steatohepatitis (MASH), an incurable metabolic disease, in collaboration with Professor Baek Moon-chang of Kyungpook National University School of Medicine.